BWC0977
Sponsors
Bugworks Research Inc.
Conditions
Antimicrobial Drug ResistanceBacterial InfectionsInfectious Diseases
Phase 1
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
CompletedNCT05088421
Start: 2021-11-05End: 2023-05-28Updated: 2023-07-06
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
TerminatedNCT05942820
Start: 2023-08-30End: 2024-02-15Updated: 2024-03-20
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
RecruitingNCT07029932
Start: 2025-10-10End: 2026-08-30Target: 48Updated: 2025-11-24